Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; the American Academy of Neurology (A.B.), Minneapolis, MN; the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse, NY; the Department of Neurology (M.P., C.B.), University of Maryland School of Medicine, Baltimore; University of California Los Angeles (E.C.); and the MS Center of Excellence and the Research and Neurology Services (C.B.), VA Maryland Health Care System, Baltimore.
Alexander
A
Rae-Grant
From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; the American Academy of Neurology (A.B.), Minneapolis, MN; the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse, NY; the Department of Neurology (M.P., C.B.), University of Maryland School of Medicine, Baltimore; University of California Los Angeles (E.C.); and the MS Center of Excellence and the Research and Neurology Services (C.B.), VA Maryland Health Care System, Baltimore.
Amy
A
Bennett
From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; the American Academy of Neurology (A.B.), Minneapolis, MN; the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse, NY; the Department of Neurology (M.P., C.B.), University of Maryland School of Medicine, Baltimore; University of California Los Angeles (E.C.); and the MS Center of Excellence and the Research and Neurology Services (C.B.), VA Maryland Health Care System, Baltimore.
Amy E
AE
Sanders
From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; the American Academy of Neurology (A.B.), Minneapolis, MN; the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse, NY; the Department of Neurology (M.P., C.B.), University of Maryland School of Medicine, Baltimore; University of California Los Angeles (E.C.); and the MS Center of Excellence and the Research and Neurology Services (C.B.), VA Maryland Health Care System, Baltimore.
Michael
M
Phipps
From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; the American Academy of Neurology (A.B.), Minneapolis, MN; the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse, NY; the Department of Neurology (M.P., C.B.), University of Maryland School of Medicine, Baltimore; University of California Los Angeles (E.C.); and the MS Center of Excellence and the Research and Neurology Services (C.B.), VA Maryland Health Care System, Baltimore.
Eric
E
Cheng
From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; the American Academy of Neurology (A.B.), Minneapolis, MN; the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse, NY; the Department of Neurology (M.P., C.B.), University of Maryland School of Medicine, Baltimore; University of California Los Angeles (E.C.); and the MS Center of Excellence and the Research and Neurology Services (C.B.), VA Maryland Health Care System, Baltimore.
Christopher
C
Bever
D000047:Academies and Institutes / Q000592:standards* / Q000639:trends; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009462:Neurology / Q000592:standards* / Q000639:trends; D058996:Quality Improvement / Q000592:standards* / Q000639:trends; D014481:United States / Q000453:epidemiology